Fabtech

Mumbai, India Founded: 2002 • Age: 24 yrs
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured.
Annual revenue $37.7M Latest available
Total funding $175,048 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors 7 Brand Intelligence

About Fabtech

Fabtech is a company based in Mumbai (India) founded in 2002 by Aasif Ahsan Khan. It operates as a Professional Services. Fabtech has raised $175.05 thousand across 1 funding round from investors including Acaciaa International TR LLC. Fabtech offers products and services including Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process. Fabtech operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.

  • Headquarter Mumbai, India
  • Founders Aasif Ahsan Khan
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Fabtech Technologies Limited
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $37.69 M (USD)
    43.74
    as on Mar 31, 2025
  • Net Profit
    $5.44 M (USD)
    70.67
    as on Mar 31, 2025
  • EBITDA
    $4.43 M (USD)
    9.93
    as on Mar 31, 2025
  • Total Equity Funding
    $175.05 K (USD)

    in 1 rounds

  • Latest Funding Round
    $175.05 K (USD), Seed

    Feb 28, 2012

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Fabtech

Fabtech is a publicly listed company on the NSE with ticker symbol FABTECH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: FABTECH · Sector: Health technology · India

Products & Services of Fabtech

Fabtech offers a comprehensive portfolio of products and services, including Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process.

Product name locked
Category locked
Primary

Complete turnkey solutions for pharmaceutical manufacturing are provided.

Product name locked
Category locked
Locked

Air quality solutions for pharmaceutical facilities are offered.

Product name locked
Category locked
Locked

Water treatment solutions for pharmaceutical processes are delivered.

Product name locked
Category locked
Locked

Process optimization solutions for pharmaceutical production are provided.

People of Fabtech

Headcount 500-1000
Employee Profiles 30
Employee Profiles
People
Mrunalini Chaudhari
Head Of Strategy
People
Rushin Shah
Head - Corporate Marketing
People
Akbar Memon
Deputy General Manager- International Sales
People
Imteyaz Ahamad
Manager

Unlock access to complete

Funding Insights of Fabtech

Fabtech has successfully raised a total of $175.05K through 1 strategic funding round. The most recent funding activity was a Seed round of $175.05 thousand completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Fabtech

Fabtech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Acaciaa International TR LLC.

All
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Premium access

Investor details for Fabtech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fabtech

Investments
Premium access

Investment portfolio details for Fabtech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Fabtech

Premium access

Detailed financials for Fabtech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fabtech Comparisons

Fabtech Primary company
Description
Instruments for biotech, pharmaceutical, and biomedical sect...
Location
Mumbai, India
Founded Year
2002
Annual Revenue
$37.69 M (USD)
Net Profit
$5.44 M (USD)
EBITDA
$4.43 M (USD)
Employees
Not available
Premium access

Peer comparison for Fabtech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Fabtech

Fabtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
Healthcare access in Asia is enhanced by Zuellig Pharma.
Locked Locked Locked
Inventory, order and customer relationship management solution for life science suppliers.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Locked Locked Locked
Technology-based consultancy and product development services are provided.
Locked Locked Locked
Strategic consulting services are provided to life sciences companies.
Premium access

Detailed competitors of Fabtech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fabtech

Premium access

Complete news archive for Fabtech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fabtech

Fabtech was founded in 2002 and raised its 1st funding round 10 years after it was founded.

Fabtech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Fabtech is a funded company, having raised a total of $175.05K across 1 funding round to date.

Annual revenue of Fabtech is $37.69M as on Mar 31, 2025.

Turnkey engineering solutions for pharmaceutical, biotech, and healthcare companies are delivered by Fabtech. Operations span across 62 countries, serving over 1300 customers. Solutions include start-to-finish engineering, air quality systems, water treatment, and process optimization. The mission to make medicines affordable and accessible is pursued by building pharmaceutical capabilities globally. Partnerships with bio-pharma companies in regions like West Africa, Latin America, and North Africa are established to enhance indigenous drug manufacturing.

Fabtech's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Fabtech offers Start-to-Finish Solutions, Solutions for Air, Solutions for Water, and Solutions for Process.

Yes, Fabtech is publicly traded on NSE under the ticker symbol FABTECH.

Fabtech has 1 investor. Key investors include Acaciaa International TR LLC.

The ticker symbol of Fabtech is FABTECH on NSE.

The valuation of Fabtech is $30.98M as of Feb 2012.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available